Cidara Therapeutics Inc (CDTX)
13.43
+0.40
(+3.07%)
USD |
NASDAQ |
Nov 05, 16:00
13.43
0.00 (0.00%)
After-Hours: 18:22
Cidara Therapeutics Market Cap: 94.52M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 91.71M |
| November 01, 2024 | 92.13M |
| October 31, 2024 | 91.50M |
| October 30, 2024 | 90.30M |
| October 29, 2024 | 94.24M |
| October 28, 2024 | 87.77M |
| October 25, 2024 | 88.68M |
| October 24, 2024 | 78.55M |
| October 23, 2024 | 79.53M |
| October 22, 2024 | 80.09M |
| October 21, 2024 | 78.97M |
| October 18, 2024 | 79.25M |
| October 17, 2024 | 78.48M |
| October 16, 2024 | 75.59M |
| October 15, 2024 | 71.58M |
| October 14, 2024 | 72.49M |
| October 11, 2024 | 74.68M |
| October 10, 2024 | 74.04M |
| October 09, 2024 | 76.36M |
| October 08, 2024 | 75.38M |
| October 07, 2024 | 78.34M |
| October 04, 2024 | 76.72M |
| October 03, 2024 | 75.31M |
| October 02, 2024 | 74.25M |
| October 01, 2024 | 74.68M |
| Date | Value |
|---|---|
| September 30, 2024 | 75.66M |
| September 27, 2024 | 75.59M |
| September 26, 2024 | 75.94M |
| September 25, 2024 | 76.15M |
| September 24, 2024 | 75.80M |
| September 23, 2024 | 76.51M |
| September 20, 2024 | 79.32M |
| September 19, 2024 | 82.49M |
| September 18, 2024 | 81.78M |
| September 17, 2024 | 81.85M |
| September 16, 2024 | 83.05M |
| September 13, 2024 | 84.04M |
| September 12, 2024 | 79.88M |
| September 11, 2024 | 81.78M |
| September 10, 2024 | 84.11M |
| September 09, 2024 | 82.35M |
| September 06, 2024 | 80.52M |
| September 05, 2024 | 81.29M |
| September 04, 2024 | 79.64M |
| September 03, 2024 | 81.57M |
| August 30, 2024 | 83.68M |
| August 29, 2024 | 91.14M |
| August 28, 2024 | 91.21M |
| August 27, 2024 | 91.29M |
| August 26, 2024 | 90.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
29.55M
Minimum
May 13 2022
176.24M
Maximum
Mar 21 2023
88.50M
Average
88.88M
Median
Dec 10 2019
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.59B |
| Arbutus Biopharma Corp | 746.63M |
| GlycoMimetics Inc | 25.14M |
| FibroGen Inc | 30.52M |
| Cue Biopharma Inc | 102.65M |
Market Cap Related Metrics
| PS Ratio | 1.559 |
| PEG Ratio | -0.0006 |
| Price to Book Value | 0.7219 |
| Price | 13.43 |
| Earnings Yield | -188.2% |
| PEGY Ratio | -0.0006 |